• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical ...

    Research and Markets: Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

  2. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

  3. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.